1. Belec, J., Sutherland, J., Volpini, M, Rakhra K, Granville D, La Russa D, Flaxman T, De Oliveira EP, Glikstein R, dos Santos M, MacPherson M, Aviv R, Nair V. A Pilot Clinical and Technical Validation of an Immersive Virtual Reality Platform for 3D Anatomical Modeling and Contouring in Support of Surgical and Radiation Oncology Treatment Planning. J Digit Imaging. Inform. med. (2024). https://doi.org/10.1007/s10278-024-01048-3

2. Al-Mansor E, Mahoney M, Chenard-Poirier M, Ramjeesingh R, Nair V, Kennedy E, Locke G,Welch S, Berry S, Couture F, et al. Eastern Canadian Gastrointestinal Cancer Consensus Conference 2023. Current Oncology. 2023; 30(9):8172-8185.
https://doi.org/10.3390/curroncol30090593Zheng K, Bassal M, Mitsakakis N, Cepalo

3. T, Hamid JS, Momoli F, Reisman J, Nair V, Radhakrishnan D. A longitudinal analysis of early lung function trajectory in survivors of childhood Hodgkin lymphoma. Cancer Rep (Hoboken). 2023 Jan;6(1):e1661. doi: 10.1002/cnr2.1661. Epub 2022 Jun 27. PMID: 35760768; PMCID: PMC9875613.

4. Volpini ME, Song J, Samant R, MacDonald D, Nair VJ. Cranial Radiation Therapy as Salvage in the Treatment of Relapsed Primary CNS Lymphoma. Curr Oncol. 2022 Oct 28;29(11):8160-8170. doi: 10.3390/curroncol29110644. PMID: 36354704; PMCID: PMC9689217.

5. Puac-Polanco P, Zakhari N, Miller J, McComiskey D, Thornhill RE, Jansen GH, Nair VJ,Nguyen TB. Diagnostic Accuracy of Centrally Restricted Diffusion Sign in Cerebral Metastatic Disease: Differentiating Radiation Necrosis from Tumor Recurrence. Can Assoc Radiol J. 2022 Jul 18:8465371221115341. doi: 10.1177/08465371221115341.Epub ahead of print. PMID: 35848632.

6. Gauthier ID, Macleod CA, Sathiadoss P, McGrath TA, Nair V, Schieda N. Risk of
nephrogenic systemic fibrosis (NSF) in oncology patients receiving gadoxetic acid andupdated risk of estimate of NSF in patients receiving gadoxetic acid with moderate and severe renal impairment. Abdom Radiol (NY). 2022 Mar;47(3):1196-1201. doi:10.1007/s00261-021-03367-3. Epub 2022 Jan 7. PMID: 34997298.

7. Zuccato JA, Algan O, Nair VJ, Gunter T, Glenn CA, Dunn IF, Fung KM, Shultz DB, Zadeh G,Laperriere N, Tsang DS. Resection and radiotherapy for intracranial ependymoma: a multiinstitutional 50-year experience. J Neurosurg. 2021 Dec 24:1-8. doi:10.3171/2021.9.JNS211299. Online ahead of print. PMID: 349525121.

8.Gotfrit J, Goodwin R, Asmis T, Hyde AJ, Alcindor T, Aubin F, Berry S, Bossé D, Brown C, Burkes R, Burnell M, Colwell B, Corbett J, Craswell J, Daaboul N, Doherty M, Fleming DAB, Galvis L, Goel R, Harb M, Jeyakumar A, Jonker D, Kennedy E, Lock M, Mahmud A, McCrea PH, Nair V, Nassabein R, Nessim C, Ramjeesingh R, Raza M, Saliba W, Samimi S, Singh S, Snow S, Tehfé M, Thirlwell M, Valdes M, Welch S, Vickers M. Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019. Curr Oncol. 2021 May 26;28(3):1988-2006. doi: 10.3390/curroncol28030185.

9. Burgess L, Nair V, Gratton J, Doody J, Chang L, Malone S. Stereotactic radiosurgery optimization with hippocampal-sparing in patients treated for brain metastases. Physics and Imaging in Radiation Oncology.2021,17, 106-110.

10. Song J, Samant R, Jay M, Chaudry H, Fan XY, MacDonald D, Bence-Bruckler I, Nair V. Whole brain radiotherapy improves survival outcomes in primary CNS lymphoma patients ineligible for systemic therapy. Support Care Cancer. 2020 Nov;28(11):5363-5369. doi: 10.1007/s00520-020-05376-2. Epub 2020 Mar 5. PMID: 32140974.

11. Song J, Tang T, Caudrelier JM, Bélec J, Chan J, Lacasse P, Aldosary G, Nair V. Dose-sparing effect of deep inspiration breath hold technique on coronary artery and left ventricle segments in treatment of breast cancer. Radiother Oncol. 2020 Sep 17;154:101-109. doi: 10.1016/j.radonc.2020.09.019. Epub ahead of print. PMID: 32950530.

12. Nair VJ, Caudrelier JM. Hypofractionated radiotherapy for elderly breast cancer patients: from early stages disease to local palliation for unresectable disease. Translational Cancer Research. 2019. 

All Other Publications

11. Holmes OE, MacRae R, Cook G, Cross P, Nair V, Marginean H, Pantarotto JR. Age-not Charlson Co-morbidity Index-predict for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer. Clinical and Translational Radiation Oncology. Volume 5, August 2017, 37-41.

12. Nair VJ, Szanto J, Vandervoort E, Henderson E, Avruch L, Malone S, Pantarotto J. Feasibility, detectability and clinical experience with platinum fiducial seeds for MRI/CT fusion and real-time tumor tracking during CyberKnife® stereotactic ablative radiotherapy. J Radiosurg SBRT. 2015; 3(4):315-323.

13. Gupta T, Nair V, Jalali R. Stem cell niche irradiation in glioblastoma: providing a ray of hope? CNS Oncol. 2014;3(5):367-76. doi: 10.2217/cns.14.39. 9. Nair VJ, Pantarotto JR. Treatment of metastatic liver tumors using stereotactic ablative radiotherapy. World J Radiol. 2014 Feb 28;6(2):18-25. doi: 10.4329/wjr.v6.i2.18.

14. Nair VJ, Malone C, Moretto P, Leung E, Malone S (2014) Bone-Seeking Targeted Radio-Nuclide Therapy (BT-RNT) in Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC): Shifting from Palliation to Improving Survival. J Nucl Med Radiat Ther. 2014; 6:202. doi:10.4172/2155-9619.1000202

15. Nair VJ, MacRae R, Sirisegaram A, Pantarotto J. Pretreatment [18F]-fluoro-2-deoxy-glucose positron emission tomography maximum standardized uptake value as predictor of distant metastasis in early-stage non-small cell lung cancer treated with definitive radiation therapy: rethinking the role of positron emission tomography in personalizing treatment based on risk status. Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):312-8. doi: 10.1016/j.ijrobp.2013.10.029.

16. Nair VJ, Szanto J, Vandervoort E, Cagiannos I, Breau R, Malone C, Avruch L, Pantarotto J, Malone S. CyberKnife for inoperable renal tumors: Canadian pioneering experience. Can J Urol. 2013 Oct;20(5):6944-9.

17. Gupta T, Nair V, Paul SN, Kannan S, Moiyadi A, Epari S, Jalali R. Can irradiation of potential cancer stem-cell niche in the subventricular zone influence survival in 
patients with newly diagnosed glioblastoma? J Neurooncol. 2012 Aug;109(1):195-203. Epub 2012 May 4.

18. Gupta T, Jalali R, Goswami S, Nair V, Moiyadi A, Epari S, Sarin R. Early clinical outcomes demonstrate preserved cognitive function in children with average-risk medulloblastoma when treated with hyperfractionated radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1534-40. Epub 2012 Feb 16.

19. Moretto P, Nair VJ, Hallani SE, Malone S, Belanger E, Morash C, Canil CM. Management of penoscrotal extramammary Paget disease: case series and review of the literature. Curr Oncol. 2013 Aug;20(4):e311-20. doi: 10.3747/co.20.1353.

20. Gupta T, Nair V, Epari S, Pietsch T, Jalali R. Concordance between local, institutional, and central pathology review in glioblastoma: implications for research and practice: a pilot study. Neurol India. 2012 Jan-Feb;60(1):61-5.

21. Gupta T, Nair V, Phurailatpam R, Jalali R, Sarin R. Hyperfractionated craniospinal re- irradiation for recurrent/progressive disseminated medulloblastoma using image-guided radiotherapy: leveraging radiobiology with technology. Journal of Radiation Oncology. 2012; 1(1): 87-92. DOI: 10.1007/s13566-012-0005-3.

22. Nair VJ, Kaushal V, Atri R. Pure Squamous Cell Carcinoma of the Breast Presenting as a Pyogenic Abscess: A Case Report. Clinical Breast Cancer. Aug. 2007; 7(9): 713-5. ISSN:1526-8209. PMID: 17919353

23. Nair V, Rattan KN, Kaushal V, Atri R, Dhankhar R, Kaur P, Kadian J. Non-Familial Pediatric Colorectal Cancers-An 18 Years’ Experience. Trop Gastroenterol. 30 (1). 2009 Jan- Mar: 51-53 [NLM ID: 8107122]

24. Rattan KN, Nair VJ, Pathak M, Kumar S. Pediatric chylolymphatic mesenteric cyst. A separate entity from cystic lymphangioma: a case series. J Med Case Reports. 2009 Nov 9;3:111. [NLM ID: 101293382]

25. Rattan KN, Kadian YS, Nair VJ, Kaushal V, Duhan N, Aggarwal S. Primary retroperitoneal teratomas in children: A single institution experience. Afr J Paediatr Surg 2010; 7:5-8. ISSN 0189-6725 (Print) 0974-5998 (Electronic) [NLM ID: 101255062]

26. Nair V, Gupta T, Jalali R, Epari S, Desai S, Rekhi B. Meningeal Hemangiopericytoma With Delayed Extra-neuraxial Metastases: Diagnostic Conundrum And Management Using High-precision Simultaneous Multi-target Irradiation On Helical Tomotherapy. WebmedCentral RADIATION ONCOLOGY 2010;1(10):WMC00949. doi: 10.9754/journal.wmc.2010.00949


Poster or abstract Presentations

1. Boucher-Routhier M, Szanto J, Thivierge JP, Nair VJ. Neuromodulatory Effect and DoseResponse of Functional Radiosurgery on Cortical Neurons. International Radiosurgery Society Milan 2022

2. Boucher-Routhier M, Szanto J, Thivierge JP, Nair VJ. Alterations in Cortical Network Activity Following Acute Radiotherapy. CAN-ACN 2022 Meeting May 12-15 in Toronto

3. Boucher-Routhier M, Szanto J, Thivierge JP, Nair VJ. Alterations in Cortical Network 9 | Curriculum Vitae Dr. Vimoj J. Nair Updated as of March 2022 Activity Following Acute Radiotherapy. CARO 2022. Toronto

4. Hiremath S, Massicotte-Tisluck K, Nair V, Zakhari N, Nguyen T. Is it treatment related change or disease progression? -Looking beyond size with diffusion and perfusion imaging. RNSA 2021. [Winner of Cum Laude award for education exhibit]

5. Volpini M, Jooya A, La Russa D, Sutherland J, Samant R, Nair V. PO-1730 Feasibility of Virtual Reality-based target volume delineation for craniospinal irradiation ESTRO 2021. Radiotherapy and Oncology, Volume 161, Supplement 1,2021, Page S1454. ISSN 0167- 140, https://doi.org/10.1016/S0167-8140(21)08181-0

6. Volpini M, Song J, Samant R, MacDonald, Nair V. PO-1060 Cranial radiotherapy as salvage treatment in relapsed primary CNS lymphomas. ESTRO 2021. Radiotherapy and Oncology, Volume 161, Supplement 1, 2021, Page S881. ISSN 0167-8140. https://doi.org/10.1016/S0167-8140(21)07511-3.

7. Zuccato J, Algan O, Nair V, Gunter T, Glen C, Dunn I, Fung K, Shultz D, Zadeh G, Laperriere N, Tsang D. Surgical Resection and Radiotherapy for Intracranial Ependymoma – A Multi-institutional, 50-year Experience. American Association of Neurological surgeons (AANS) Annual Meeting 2021.

8. Song J, Belec J, Caudrelier JM, Lacasse P, Aldosary G, Nair V. Dose-Sparing Effect of Deep Inspiration Breath Hold Technique (DIBH) on Coronary Artery Segments. ASTRO’S 60TH Annual meeting. Int J Radiat Oncol Biol Phys Sept, Sept 2019; 105 (1), Supplement: E712. WINNER OF ASTRO RESIDENT TRAVEL GRANT 2019.

9. Zheng J, Hinduja R, Pantarotto JR, Cook GG, Nair V, MacRae RM. Outcome Differences Between Early-Stage Adenocarcinoma and Squamous Cell Carcinoma Lung Cancers Treated with Stereotactic Body Radiation Therapy: Results of a Large Canadian Single Center Retrospective Analysis. ASTRO’S 60TH Annual meeting. Int J Radiat Oncol Biol Phys Sept 2019. Volume 105, Issue 1, E544 - E545.

10. Gaviolli E, Zheng J, Sinclair J, Szanto J, Alkherayf F, Malone J, Nair V, Gratton J, Malone S. Long term results of 120 cases of vestibular schwannoma treated with cyberknife robotic stereotactic radiosurgery at the ottawa hospital cancer centre. Presented at CARO Annual scientific meeting, Oct 2019 Halifax. (ORAL ABSTRACT PRESENTATION)

11. Zheng J, Hinduja R, Pantarotto JR, Cook GG, Nair V, MacRae RM. Outcome Differences Between Early-Stage Adenocarcinoma and Squamous Cell Carcinoma Lung Cancers Treated with Stereotactic Body Radiation Therapy: Results of a Large Canadian Single Center Retrospective Analysis. Radiotherapy and Oncology, 139: S49-S50. Presented at CARO Annual scientific meeting, Oct 2019 Halifax.

12. Song J, Belec J, Caudrelier JM, Lacasse P, Aldosary G, Nair V. Dose-Sparing Effect of Deep Inspiration Breath Hold Technique (DIBH) on Coronary Artery Segments. Radiotherapy and Oncology, 139: S51-S52. Presented at CARO Annual scientific meeting, Oct 2019, Halifax.

13. Song J, Samant R, Fan XY, Jay M, Chaudry H, MacDonald D, Bence-Bruckler I, Nair V. Age as an independent predictive factor for survival outcomes in primary CNS lymphoma: a 10 | Curriculum Vitae Dr. Vimoj J. Nair Updated as of March 2022 review from tertiary institution. Radiotherapy and Oncology, 139: S52. Presented at CARO Annual scientific meeting, Oct 2019 Halifax.

14. Song J, Samant R, Fan XY, Jay M, Chaudry H, MacDonald D, Bence-Bruckler I, Nair V. Palliative Cranial Irradiation Improves Survival in Primary CNS Lymphoma Patients Ineligible for Systemic Therapy. Radiotherapy and Oncology, 139: S53. Radiotherapy and Oncology, 139: S57. Presented at CARO Annual scientific meeting, Oct 2019 Halifax.

15. Burgess L, Gratton J, Doody J, Nair V, Malone S. Dosimetric Study of Hippocampal Sparing in Patients Treated with Cyberknife for Brain Metastases. Presented at CARO Annual scientific meeting, Oct 2019 Halifax.


16. Hinduja R, Seely J, Gupta a, Nair VJ, Cook G, MacRae RM. Feasibility and outcomes of radiofrequency ablation as Salvage modality after Hypofractionated Radiation/SBRT for Early NSCLC. IASLC World Conference on Lung Cancer. Toronto Canada. Sept 2018. P2.16- 19.

17. Samant R, Nyiri B, Gerig L, Bahm J, Andrusyk S, Nair V, Kew A, McCurdy A, Figueiredo A, Bredeson C, Atkins H. Evaluating dose-escalated total marrow irradiation (TMI) for relapsed multiple myeloma. Presented at CARO Annual scientific meeting, Sept 2018, Montreal.

18. Zheng K, Bassal M, Reisman J, Nair V, Momoli F, Hamid J, Cepalo T, Radhakrishnan D. Long term effects of pulmonary toxic therapy on lung function in Childhood Hodgkin’s Lymphoma and Embryonal Tumour Survivors. Summer studentship Poster presentation. 27th Sept 2018 at CHEO, Ottawa.

19. Bassal M, Story E, Chang L, Nair VJ, Reisman J, Voduc Nha, Radhakrishnan D. Assessment of pulmonary function abnormalities in adult survivors of childhood cancers. 2018 Cancer survivorship symposium. Feb 17th, 2018. J Clin Oncol 36, 2018 (suppl 7S; abstr 117).

20. Samant R, Sabloff M, Atkins H, Altouri S, Kekre N, Bredeson C, Huebsch L, Ramsay T, Allan D, Fulcher J, Nair V. High dose total body irradiation for refractory acute myeloid leukemia. Int J Radiat Oncol Biol Phys. 99(2), S179. ASTRO`S 59th Annual meeting 2017.

21. Story E, Radhakrishnan D, Voduc Nha, Chang L, Nair VJ, Reisman J, Bassal M. Assessment of pulmonary function abnormalities in adult survivors of childhood cancer. 15th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer. June 15-17, 2017, Atlanta, Georgia.

22. Sutherland J, Pantarotto J, Nair V, Cook G, Plourde M, Vandervoort E. Breathing Motion of Liver Segments from Fiducial Tracking During Robotic Radiosurgery and Comparison with 4D-CT-Derived Fiducial Motion. AAPM Annual meeting, July 2015, Anaheim, CA.

23. Nair VJ, MacRae R, Pantarotto J. Stereotactic Ablative Radiotherapy (SABR) of Centrally Located Early-Stage Lung Cancer Accrued to RTOG 0813: Novel Scoring System to Compare Plan Quality of Volumetric Modulated Arc Therapy (VMAT) versus Robotic Radiosurgery. World Conference on Lung Cancer, October 2013, Sydney, Australia.

24. Nair VJ, MacRae R, Lee T, Sirisegaram A, Pantarotto J. Pre-treatment 18FDG-PET SUVmax As a Predictor of Distant Metastasis in Early Stage NSCLC Treated with 11 | Curriculum Vitae Dr. Vimoj J. Nair Updated as of March 2022 Definitive Radiotherapy. World Conference on Lung Cancer, October 2013, Sydney, Australia.

25. Nair VJ, MacRae R, Seely J, Kendall W. Radiofrequency ablation (RFA) for the treatment of postradiation locally recurrent medically inoperable non-small cell lung cancer (NSCLC): review of feasibility and outcomes at the Ottawa Hospital Cancer Centre. Presented at CARO Annual scientific meeting, Sept 2013, Montreal.

26. Pantarotto J, Nair VJ, MacRae R. Initial Single Institution Experience with Lung SABR: 3 Year Follow up Data to Compare Local Control With those of Published Prospective Clinical Trials. Presented at CARO Annual scientific meeting, Sept 2013, Montreal.

27. Holmes O, Nair V, MacRae R, Cross P, Pantarotto J. Age-Adjusted Charlson Comorbidity Index as a predictor of survival in medically inoperable early-stage Non-Small Cell Lung Cancer patients treated with definitive radiotherapy. Presented at CARO Annual scientific meeting Sept 2013, Montreal.

28. Nair VJ, Szanto J, Vandervoort E, Henderson E, Avruch L, Malone S, Pantarotto J. Feasibility, Detectability and Experience with Platinum Seed Internal Fiducial Markers for CT-MRI Fusion and Real-time Tumor Tracking During Stereotactic Ablative Radiotherapy. Presented at ASTRO 54th Annual Meeting 2012 and CARO Annual scientific meeting 2012.

29. Nair VJ, MacRae R, Ploquin N, Clark B, Pantarotto J. A practical and objective scoring method for dosimetric comparison of individual stereotactic ablative radiotherapy treatment plans. Presented at CARO Annual scientific meeting 2012.

30. Nair VJ, Sirisegaram A, Nicholas G, Mallick R, Laurie S, MacRae R. Higher Dose Thoracic Radiotherapy is Associated with Improved Overall Survival in Limited-stage Small Cell Lung Cancer: Analysis of the 15 Year Experience from a Retrospective Cohort of 296 Patients at the Ottawa Hospital Cancer Centre (TOHCC). Poster presented at ASTRO 54thAnnual Meeting 2012, CARO Annual scientific meeting 2012 (Poster Presentation) and Chicago Multidisciplinary Symposium in Thoracic Oncology 2012.

31. Nair VJ, Szanto J, Vandervoort E, Cagiannos I, Avruch L, Pantarotto J. Nephron-sparing robotic stereotactic ablative radiotherapy (SABR) using cyberknife® for medically inoperable primary renal tumors and tumors arising from solitary kidney: report of feasibility, technique, efficacy and safety. Presented at CARO Annual scientific meeting 2012.

32. Nair VJ, MacRae R, Lee T, Sirisegaram A, Pantarotto J. Prognostic Importance of the Maximum Standardized Uptake Value (SUVmax) on [18F]-fluoro-2-deoxy-glucosePositron Emission Tomography (FDG-PET) Scan in Medically Inoperable Stage I NonSmall Cell Lung Cancer: Grounds for PET-guided Adapted Dose Escalation. Presented at Chicago Multidisciplinary Symposium in Thoracic Oncology 2012.

33. Epari S, Nair V, Gupta T, Patil P, Moiyadi A, Shetty P, Kane S, Jalali R. Pilomyxoid astrocytomas: review of clinicopathological features in a series of twenty cases. In Abstracts from the 15th International Symposium on Pediatric Neuro-Oncology, June 24- 27, 2012, Toronto, Ontario, Canada. Neuro Oncol (2012) 14 (suppl 1): i69-i81. 12 | Curriculum Vitae Dr. Vimoj J. Nair Updated as of March 2022
doi:10.1093/neuonc/nos092.

34. Gupta T, Jalali R, Goswami S, Sarin R, Nair V, Merchant N, Moiyadi A. Optimizing the physical and biological parameters in the radiotherapeutic management of average-risk medulloblastoma. Presented at ESTRO 29, Barcelona, Spain, 12-16 September 2010.

35. Atri R, Nair VJ, Kaur P, Dhankhar R, Kaushal V. Primary Melanoma of Anal Canal- A Case Report. In Conference Proceedings Educational Book RGCON 2008, 7th International Conference 7 th to 8 th March 2008.

36. Kaur P, Nair VJ, Atri R, Dhankhar R, Mittal KK, Dhull A, Paul M, Kaushal V. Primary Non-Hodgkin’s Lymphoma of Rectum. In Conference Proceedings Educational Book RGCON 2008, 7 th International Conference 7 th to 8 th March 2008

37. Mittal K, Nair VJ, Atri R, Dhankhar R, Khurana A, Kaushal V. Primary Poorly differentiated synovial sarcoma of the lung- A Case Report. In conference Proceedings Educational Book. RGCON 2009, 8 th International Conference 28th to 29 th March 2009.

For more publications use this PubMed ID link.